Interestingly, comparison to mild disease presentation, though in the fatal group, levels of anti-NP IgA significantly decreased in comparison to severe COVID-19, suggesting that this could be a relevant indication of disease aggravation and evolution to death. The gene discussed is CD79A; the disease is COVID-19.